SML0120
哌克昔林 马来酸盐
≥98% (HPLC), CPT-1 inhibitor, powder
别名:
2-(2,2-二环己基乙基)哌啶
产品名称
哌克昔林 马来酸盐, ≥98% (HPLC)
质量水平
方案
≥98% (HPLC)
表单
powder
颜色
white to tan
溶解性
DMSO: ≥5 mg/mL
储存温度
2-8°C
SMILES字符串
OC(=O)\C=C/C(O)=O.C1CCC(CC1)C(CC2CCCCN2)C3CCCCC3
InChI
1S/C19H35N.C4H4O4/c1-3-9-16(10-4-1)19(17-11-5-2-6-12-17)15-18-13-7-8-14-20-18;5-3(6)1-2-4(7)8/h16-20H,1-15H2;1-2H,(H,5,6)(H,7,8)/b;2-1-
InChI key
JDZOTSLZMQDFLG-BTJKTKAUSA-N
基因信息
human ... CPT1B(1375), CPT2(1376), MTOR(2475)
正在寻找类似产品? 访问 产品对比指南
相关类别
一般描述
马来酸哌克昔林可调节冠状血管舒张并阻止运动性心动过速。它可用于治疗心绞痛和变异型心绞痛。马来酸哌克昔林是一种心脏代谢剂。它与周围神经病变、颅内高压伴乳头水肿和近端肌病有关。
应用
马来酸哌克昔林已用于阻止脂肪酸氧化。它也被用作5′腺苷单磷酸活化蛋白激酶(AMPK)激活剂和蠕虫寿命试验。
马来酸哌克昔林用作蠕虫寿命试验的原料。它还用于阻止脂肪酸氧化。
生化/生理作用
抗心绞痛代谢调节剂；肉毒碱棕榈酰转移酶抑制剂
马来酸哌克昔林是一种抗心绞痛代谢调节剂。它能够抑制线粒体酶肉毒碱棕榈酰转移酶CPT-1并在较小程度上抑制CPT-2。这导致心肌底物利用从长链脂肪酸转变为碳水化合物，从而使葡萄糖和乳酸利用率增加，并且通过与之前相同的O2消耗而增加ATP产生，从而提高心肌效率。最近还发现马来酸哌克昔林能够抑制mTORC1的活性。
储存分类代码
11 - Combustible Solids
WGK
WGK 2
闪点(°F)
Not applicable
闪点(°C)
Not applicable
历史批次信息供参考:
分析证书(COA)
Lot/Batch Number
J D Horowitz et al.
International journal of cardiology, 13(2), 219-229 (1986-11-01)
Perhexiline maleate, which causes inhibition of myocardial fatty acid catabolism with a concomitant increase in glucose utilization, is particularly useful in the management of patients with severe angina pectoris. While perhexiline exerts no significant negative inotropic or dromotropic effects, its
Hypoglycaemia after treatment with perhexiline maleate: a case report.
Beryl Lai
The New Zealand medical journal, 124(1330), 74-77 (2011-06-18)
Sally Inglis et al.
European journal of cardiovascular nursing : journal of the Working Group on Cardiovascular Nursing of the European Society of Cardiology, 5(2), 175-184 (2006-02-14)
The ever-increasing burden of ischaemic heart disease and its common manifestation chronic angina pectoris calls for the exploration of other treatment options for those patients who despite the maximum conventional pharmacological and surgical interventions continue to suffer. Such exploration has
J D Cooper et al.
Annals of clinical biochemistry, 22 ( Pt 6), 614-617 (1985-11-01)
Patients taking oral doses of perhexiline maleate have been examined. Measurement of serum perhexiline concentrations established that different dose requirements between patients were necessary due to the different doses at which drug saturation was achieved. Measurement of serum perhexiline concentrations
C Candide et al.
European journal of clinical pharmacology, 34(2), 195-199 (1988-01-01)
The effects of perhexiline maleate (PM, Pexid) on low density lipoprotein (LDL) processing and cholesterol metabolism were investigated after a 24 h pretreatment with the drug. Perhexiline maleate increased LDL uptake in the range 10(-6) to 10(-5) M (180% of
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持